Codexis to Participate in TD Cowen 45th Annual Health Care Conference
Codexis (NASDAQ: CDXS), a leading enzymatic solutions provider for therapeutics manufacturing, has announced its participation in the TD Cowen 45th Annual Health Care Conference. The conference will take place from March 3-5, 2025, in Boston, Massachusetts.
The company's management will engage in a fireside chat on Tuesday, March 4, 2025, at 1:10 pm ET. Investors and interested parties can access a live webcast of the presentation through the Investor Relations section of Codexis's website at https://ir.codexis.com. The presentation recording will remain available for replay on the website for 90 days after the event.
Codexis (NASDAQ: CDXS), un fornitore leader di soluzioni enzimatiche per la produzione di terapie, ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Salute di TD Cowen. La conferenza si svolgerà dal 3 al 5 marzo 2025 a Boston, Massachusetts.
La direzione dell'azienda parteciperà a una chiacchierata informale il martedì 4 marzo 2025, alle 13:10 ET. Gli investitori e le parti interessate possono accedere a una trasmissione in diretta della presentazione attraverso la sezione Relazioni con gli Investitori del sito web di Codexis all'indirizzo https://ir.codexis.com. La registrazione della presentazione rimarrà disponibile per la visione sul sito web per 90 giorni dopo l'evento.
Codexis (NASDAQ: CDXS), un proveedor líder de soluciones enzimáticas para la fabricación de terapias, ha anunciado su participación en la 45ª Conferencia Anual de Salud de TD Cowen. La conferencia se llevará a cabo del 3 al 5 de marzo de 2025 en Boston, Massachusetts.
La dirección de la empresa participará en una charla informal el martes 4 de marzo de 2025, a la 1:10 pm ET. Los inversores y partes interesadas pueden acceder a una transmisión en vivo de la presentación a través de la sección de Relaciones con Inversores del sitio web de Codexis en https://ir.codexis.com. La grabación de la presentación estará disponible para su reproducción en el sitio web durante 90 días después del evento.
Codexis (NASDAQ: CDXS), 치료제 제조를 위한 효소 솔루션의 선도적인 제공업체, TD Cowen 제45회 연례 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 컨퍼런스는 2025년 3월 3일부터 5일까지 매사추세주 보스턴에서 열립니다.
회사의 경영진은 2025년 3월 4일 화요일 오후 1시 10분 ET에 비공식 대화에 참여할 예정입니다. 투자자와 이해관계자들은 Codexis 웹사이트의 투자자 관계 섹션을 통해 프레젠테이션의 생중계를 접속할 수 있으며, https://ir.codexis.com에서 확인할 수 있습니다. 프레젠테이션 녹화는 이벤트 후 90일 동안 웹사이트에서 재생할 수 있습니다.
Codexis (NASDAQ: CDXS), un fournisseur leader de solutions enzymatiques pour la fabrication de thérapies, a annoncé sa participation à la 45e Conférence Annuelle sur la Santé de TD Cowen. La conférence se déroulera du 3 au 5 mars 2025 à Boston, Massachusetts.
La direction de l'entreprise participera à une discussion informelle le mardi 4 mars 2025, à 13h10 ET. Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la section Relations Investisseurs du site web de Codexis à l'adresse https://ir.codexis.com. L'enregistrement de la présentation sera disponible en replay sur le site pendant 90 jours après l'événement.
Codexis (NASDAQ: CDXS), ein führender Anbieter enzymatischer Lösungen für die Herstellung von Therapeutika, hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen bekannt gegeben. Die Konferenz findet vom 3. bis 5. März 2025 in Boston, Massachusetts, statt.
Das Management des Unternehmens wird am Dienstag, den 4. März 2025, um 13:10 Uhr ET an einem informellen Gespräch teilnehmen. Investoren und interessierte Parteien können über den Bereich Investor Relations auf der Website von Codexis unter https://ir.codexis.com auf einen Live-Stream der Präsentation zugreifen. Die Aufzeichnung der Präsentation wird 90 Tage nach der Veranstaltung auf der Website zum Abruf bereitstehen.
- None.
- None.
REDWOOD CITY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the TD Cowen 45th Annual Health Care Conference, being held March 3-5, 2025, in Boston, Massachusetts.
Management will participate in a fireside chat on Tuesday, March 4, 2025, at 1:10 pm ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay will be archived for 90 days following the event.
About Codexis
Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com
Media Contact
Lauren Musto
(650) 421-8205
media@codexis.com
FAQ
When is Codexis (CDXS) presenting at the TD Cowen Health Care Conference 2025?
How can investors watch Codexis's (CDXS) presentation at the TD Cowen conference?
How long will the replay of Codexis's (CDXS) TD Cowen conference presentation be available?
Where is the 2025 TD Cowen Health Care Conference featuring Codexis (CDXS) being held?
